PatchSiren cyber security CVE debrief
CVE-2026-17275 IBM CVE debrief
IBM i 7.3, 7.4, 7.5, and 7.6 are affected by an improper validation vulnerability. A remote attacker could perform unauthorized manipulation of distributed transactions due to improper validation of attacker-supplied transaction identifiers. The CVSS score is 3.7, and the severity is LOW. This vulnerability allows unauthorized manipulation of distributed transactions, which can have significant operational impacts. Defenders should prioritize verifying affected versions and assessing exposure.
- Vendor
- IBM
- Product
- i
- CVSS
- LOW 3.7
- CISA KEV
- Not listed in stored evidence
- Original CVE published
- 2026-10-16
- Original CVE updated
- 2026-10-16
- Advisory published
- 2026-10-16
- Advisory updated
- 2026-10-16
Who should care
Defenders responsible for IBM i systems, specifically those using versions 7.3, 7.4, 7.5, and 7.6, should assess exposure and prioritize verification and patching.
Why it matters
Defenders should care about CVE-2026-17275 because it affects IBM i versions 7.3, 7.4, 7.5, and 7.6, allowing unauthorized manipulation of distributed transactions. Exposure assessment, configuration review, and patching are crucial.
- Verify affected versions to determine exposure
- Assess distributed transaction configurations for unauthorized manipulation
- Monitor for suspicious transaction activity
- Prioritize patching when vendor-provided fixes are available
Technical summary
IBM i 7.3, 7.4, 7.5, and 7.6 are affected by an improper validation vulnerability. A remote attacker could perform unauthorized manipulation of distributed transactions due to improper validation of attacker-supplied transaction identifiers. The CVSS score is 3.7, and the severity is LOW.
Defensive priority
Defenders should prioritize verifying affected versions and assessing exposure, as the vulnerability allows unauthorized manipulation of distributed transactions.
Recommended defensive actions
- Verify affected IBM i versions (7.3, 7.4, 7.5, 7.6) and assess exposure
- Review distributed transaction configurations for unauthorized manipulation
- Monitor for suspicious transaction activity
- Apply vendor-provided patches when available
Evidence notes
The CVE record and source item provide details on the vulnerability, affected versions, and a reference to a vendor advisory. The vulnerability affects IBM i versions 7.3, 7.4, 7.5, and 7.6. The source item and CVE record provide evidence of the vulnerability and its impacts. Defenders should verify affected versions, assess distributed transaction configurations, and monitor for suspicious transaction activity. The vendor advisory provides patch information and additional guidance on
Sources and references
Verified primary and authoritative sources
-
CVE-2026-17275 CVE Program record
Publisher, destination, and source semantics verified
URL: https://www.cve.org/CVERecord?id=CVE-2026-17275
CVE Program - Official CVE Program record with source-provided CVE metadata.
-
CVE-2026-17275 NVD vulnerability detail
Publisher, destination, and source semantics verified
URL: https://nvd.nist.gov/vuln/detail/CVE-2026-17275
NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.
Supplemental references
-
IBM i is Affected by an Improper Validation Vulnerability
Unverified legacy reference
URL: https://raw.githubusercontent.com/CVEProject/cvelistV5/main/cves/2026/17xxx/CVE-2026-17275.json
cve_program_cvelist_v5
-
Source reference
Unverified legacy reference
URL: https://www.ibm.com/support/pages/node/7292222
Supplemental source - vendor-advisory, patch
Methodology and review provenance
AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.